Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Summary

The objective of this trial was to determine the efficacy and safety of linaclotide 72 ug administered once daily to patients with chronic idiopathic constipation (CIC). The primary efficacy parameter is the percentage of participants in each dosing group that meet the protocol definition for complete spontaneous bowel movement (CSBM) Overall Responder.

Timeline

Start

2014-10

Primary completion

2015-08

Completion

2015-08

Drugs

Indications